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Is Sprawl Associated with a Widening
Urban–Suburban Mortality Gap?
Yingling Fan and Yan Song
ABSTRACT This paper examines whether sprawl, featured by low development density,
segregated land uses, lack of significant centers, and poor street connectivity, contributes to
a wideningmortality gap between urban and suburban residents.We employ twomortality
datasets, including a national cross-sectional dataset examining the impact of metropolitan-
level sprawl on urban–suburban mortality gaps and a longitudinal dataset from Portland
examining changes in urban–suburban mortality gaps over time. The national and
Portland studies provide the only evidence to date that (1) across metropolitan areas, the
size of urban–suburban mortality gaps varies by the extent of sprawl: in sprawling
metropolitan areas, urban residents have significant excess mortality risks than suburban
residents, while in compact metropolitan areas, urbanicity-related excess mortality becomes
insignificant; (2) the Portland metropolitan area not only experienced net decreases in
mortality rates but also a narrowing urban–suburban mortality gap since its adoption of
smart growth regime in the past decade; and (3) the existence of excess mortality among
urban residents in US sprawling metropolitan areas, as well as the net mortality decreases
and narrowing urban–suburban mortality gap in the Portland metropolitan area, is not
attributable to sociodemographic variations. These findings suggest that health threats
imposed by sprawl affect urban residents disproportionately compared to suburban
residents and that efforts curbing sprawl may mitigate urban–suburban health disparities.
KEYWORDS Mortality, Sprawl, Smart growth, Urban health penalty, Health disparities
INTRODUCTION
Whether health disparities exist between urban and suburban residents has been
debated in the field of public health for centuries. Early cities in the nineteenth or the
early twentieth century were developed with rapid population growth in an
environment without proper sanitation. High population density coupled with
accumulation of city waste was likely to deteriorate air quality, contaminate water
supply, provide new foci of infection, and create favorable conditions for the rapid
transmission of disease from host to host—all of which led to elevated mortality
risks among urban residents.1–3 Modern city life, although offering health benefits
through improved access to medical care, sanitation, education, jobs, social support,
and higher income,4 still threatens health via greater exposure to environmental
pollutions, social stress, infections, violence, and accidents.5
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W. H. McNeil explicitly developed a conceptual model to explain variations in
mortality rates between large metropolitan centers and their more thinly settled
hinterlands.6 Central areas, he argued, act as endemic reservoirs of diseases which
spill over to their hinterlands in the form of recurrent epidemics. Urban populations
thus experience generally higher and more stable levels of mortality. Hinterland
mortality, by contrast, is less severe but is subject to violent short-term fluctuations.6
Empirical studies conducted in the 1970s and 1980s concur with McNeil’s model of
the urban health penalty. Many suggest that there is a general increased risk of death
for urban residents when compared to suburban residents.7–10 However, studies in the
1970s and 1980s inadequately controlled for confounding variables such as race,
ethnicity, and socioeconomic status. To some extent, “white flight”—the demographic
shift in the first half of the twentieth century where middle-class families moved away
from inner-city neighborhoods and where inner-city residents became equated with
disadvantaged groups such as minority and low-income households—might explain
the higher mortality rates found in urban areas in the 1970s and 1980s.4
More recent and rigorous studies on urban–suburban health disparities offer
mixed and inconsistent findings. House et al. studied a national sample of 3,617
adults and found that significant urban mortality risk exists among white men, but
not among white women.5 Surprisingly, African Americans in suburban areas were
found to have mortality risks as high as those in urban areas. Geronimus et al.
selected several pairs of African-American communities and non-Hispanic white
communities and investigated urban–rural disparities in mortality rates.11 Their
results contradict the findings of House et al., suggesting that African-American
residents of urban communities suffer extremely high and growing rate of excess
mortality. However, the contradiction may be due to the specific focus of Geronimus
et al. on urban–rural disparities, which is different from the focus of House et al. on
urban–suburban disparities. Smith et al. and Hayward et al. focused on a population
of men 55 years or older and found that excess mortality existed among urban
residents even after controlling for differences in social class and lifestyle factors
between urban and suburban residents.12,13
Although the aforementioned studies performed adjustments for population
composition and socioeconomic status, no study has yet examined how the extent of
urban–suburban health disparities in a metropolitan area may be influenced by the
region’s built environment. The built environment, encompassing all of the buildings,
spaces, and products that are created or significantlymodified by people, not only forms
a backcloth against which people live, work, and play,14 but also to some degree
determines residents’ exposure to environmental risks and the associated physiological
and psychosocial impacts.15 Thus, the built environment has a profound impact on
the health of its inhabitants, and different types of metropolitan environments (e.g.,
compact versus sprawling) each offer unique urban and suburban experiences, leading
to a varied degree of urban–suburban health disparities.
Figure 1 illustrates a conceptual framework linking the built environment to
health outcomes. The mediating factors and downstream pathways illustrated in
Figure 1 are of particular interest as they outline possible connections between the
built environment and health. Some of the meditating factors and downstream
pathways are obvious: vehicle emissions, exposure to air pollution, and respiratory
health; traffic congestion and noise, stress, and chronic diseases; and poorly
maintained neighborhoods, crime, and homicides. Others are less direct but
increasingly recognized as important, such as the relationships of land use patterns
to human activity patterns and obesity-related diseases. In this research, we apply
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the conceptual framework in Figure 1 to study how sprawl may contribute to
urban–suburban health disparities in cause-specific mortality.
Sprawl is the prevailing land development pattern in the US, featured by low
development density, segregated land uses, lack of significant centers, and poor
street connectivity. Sprawl is found to be associated with higher levels of
environmental pollution.17,18 Thereby, according to Figure 1, residents living in
sprawling metropolitan areas may experience higher levels of physical, chemical,
and biological exposure and are likely to have elevated mortality risks from tumor,
infection, or respiratory diseases. Sprawl is also found to be associated with a
sedentary lifestyle, unhealthy eating habits, and risk behaviors such as smoking,19–21
and based upon the downstream pathways illustrated in Figure 1, sprawl may lead
to a higher mortality risk from cardiovascular/heart diseases. In addition, sprawl
promotes extensive auto use and increases social polarization among communities,
which may increase crime rates, worsen traffic conditions, and make residents more
vulnerable to external causes of death.22,23
Having highlighted the underlying causes of death that are most relevant to
health threats associated with sprawl, it is important to note that, within a
metropolitan area, the health threats associated with sprawl are likely to affect
urban residents disproportionately compared to suburban residents. Sprawl
inevitably leads to decentralization and fragmentation of economic opportunities,
dramatic reductions in population size, density, diversity, and resources in urban
areas, and deprivation of economic, social, and political capitals in inner-cities, all of
which create urban–suburban health disparities and increase excess mortality risks
among urban residents. In contrast, compact development (i.e., the opposite of
sprawl) promotes “smart growth”* and often has goals targeted to prevent
*“Smart growth” is antisprawl development that values long-range, holistic considerations of
environmental protection, economic growth, and social equity over short-term fiscal considerations.
The term of “smart growth” is often used interchangeably with “growth management.” Examples of
growth management/smart growth strategies include (a) urban containment boundaries that direct urban
development into areas intended or needed for urban uses and protect rural land from urban spillovers,
(b) capital improvements programming and adequate facilities standards that discourage developments
farther away from existing civil infrastructure systems and encourage infill and redevelopments, (c) land
preservation techniques (e.g., transfer of development rights and agriculture/forest buffers) that protect
resource land from urban development pressures, etc.
FIGURE 1. A conceptual model of how the built environment impacts health. The model
presented in this figure is adapted from a conceptual model developed by Klitzman et al.16 The
model has been modified to highlight the mediating factors and downstream pathways by which
the built environment influences health outcomes.
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decentralization of economic opportunities, avoid inner-city decline, and advocate
compact, transit-oriented, walkable, and bicycle-friendly land uses.24 These policies
embrace geographic equity and promote a more balanced allocation of resources
within the metropolitan area between inner-cities and suburbs. Therefore, it is
expected that sprawling regions may observe not only higher overall mortality rates
but also a wider mortality gap between urban and suburban residents when
compared to compact regions.
This paper presents a direct effort to test this a priori expectation. To ensure the
robustness and thoroughness of the empirical test, two datasets are employed in this
paper: one has cross-sectional population, mortality, and urban form information in
the nation’s 65 largest metropolitan areas from the year 2000; another has
longitudinal population, mortality, and urban form information from 1989 to
2000 in the Portland metro’s 71 zip code areas. Analysis of the national dataset
attempts to quantify the size variation in urban–suburban mortality gaps across
different metropolitan areas and how the magnitude of mortality gaps varies as a
function of the extent of sprawl. Analysis of the Portland dataset comes with a
longitudinal design that examines whether Portland’s recent efforts on curbing
sprawl are associated with decreases in urban–suburban health disparities. The two
analyses complement each other and are intended to provide supporting empirical
evidence on the hypothesis that sprawl is positively linked to the level of urban–
suburban health disparities.
NATIONWIDE CROSS-SECTIONAL STUDY: DATA, METHOD, AND FINDINGS
This national study focuses on the 100 largest metropolitan areas during the year
2000. Boundaries of the metropolitan areas are specified using the Core Based
Statistical Areas system defined by the U.S. Office of Management and Budget
(OMB) in 2000. According to the US OMB, each metropolitan area consists of one
or more counties, encompassing (1) the counties containing a core urban area of
50,000 or more population and (2) any adjacent counties that have a high degree of
social and economic integration with the urban core. This operational definition
offers opportunities of applying a parallel-group design (i.e., matched pairs of core
urban versus suburban counties) to examine urban–suburban mortality gaps.
The final sample of this research is limited to 65 metropolitan areas because of
data availability and matching suitability of county components in each metro.
Single-county metros are either excluded from the sample (e.g., El Paso, TX and San
Diego, CA) or combined into adjacent metros (e.g., the Oakland metropolitan area
in CA is combined into the San Francisco metropolitan area). The final 65 metro
areas in the sample, as shown in Figure 2, include a total of 458 counties. The 458
counties are categorized into core urban versus suburban counties based upon their
urbanization level. Counties are coded as core urban counties if they are identified as
large central counties in the 2006 Urban–Rural Classification Scheme by the
National Center for Health Statistics (NCHS). If no counties in a metropolitan area
are coded as large central by NCHS, counties with the largest city population in the
metropolitan area are identified as the urban core county. For example, in the
Portland metropolitan area, Multnomah County is identified as the core urban
county while Washington, Clark, and Clackamas Counties are identified as
suburban counties. Finally, 79 counties are identified as core urban counties and
379 are identified as suburban counties.
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Data and Variables
County-level mortality data come from the Centers for Disease Control and
Prevention (CDC). Using the online CDC WONDER platform, 2000–2005
mortality counts by underlying cause of death in the 458 study counties are
acquired. As discussed in the “Introduction” section, we highlight the underlying
causes of death that are most relevant to health threats associated with sprawl. They
are (1) infections, (2) tumors, (3) cardiovascular diseases, (4) respiratory diseases,
and (5) external causes such as injury, suicide, and homicide. Cause-specific
mortality rates are identified using the International Classification of Diseases
(ICD) published by the World Health Organization. To date, there have been ten
revisions of the ICD. ICD-9 was used from 1979 to 1998 and ICD-10 has been used
FIGURE 2. Study area: 65 metro areas.
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since 1999. Table 1 presents the ICD-9 and ICD-10 codes corresponding to each of
the five death causes.
Sociodemographic information at the county level comes from the U.S. Census
Bureau, including age, sex, race, ethnicity, marital status, income level, and poverty.
Furthermore, a set of dummy variables are created to capture contextual differences
such as weather and climate in the nine census divisions (i.e., New England, Middle
Atlantic, East North Central, West North Central, South Atlantic, East South
Central, West South Central, West Mountain, and West Pacific).
A sprawl indicator at the metropolitan level is incorporated into mortality
models. Metropolitan-level sprawl indices have been developed by many sources,
including USA Today, Sierra Club, and independent researchers (for example,
Galster et al.).25 This paper adopts the sprawl index developed by Ewing et al. for
83 US metropolitan areas because Ewing’s index is the most recent and
comprehensive effort of measuring sprawl,26 incorporating various density, land
use mix, centrality, and street connectivity dimensions. Ewing’s sprawl index is a
metropolitan-level factor extracted from six variables through principle component
analysis: (1) gross population density (persons per square mile); (2) percentage of
population living at low suburban densities; (3) percentage of population living at
moderate to high urban densities; (4) net density in urban areas; (5) average block
size; and (6) percentage of blocks with areas less than 1/100 square mile. This factor
was transformed to a scale with a mean of 100 and a standard deviation of 25.
Larger values of the sprawl index indicate more compact metro areas, whereas
smaller values indicate more sprawling metro areas. The addition of Ewing’s sprawl
index to the national dataset allows us to examine whether Seattle (sprawl
index=100.9) would have smaller urban–suburban mortality gaps if it were as
compact as Portland (sprawl index=126.0) after controlling for sociodemographics.
Regression Model
At the first glance, Poisson regression is appropriate for this analysis because our
dependent variables are mortality rates. However, descriptive analysis shows
overdispersion in all-cause and cause-specific mortality rates, which contradicts the
assumption of Poisson distribution (i.e., the assumption that the mean is equal to the
variance). To address this issue, we estimate mortality models using generalized
linear models (commonly referred to as GLZ)**—an approach that places fewer
restrictions on model parameters. The GLZ approach allows the variance to be
adjusted independently of the mean and thereby relaxes the requirement of equality
TABLE 1 ICD codes for five specific underlying causes of death
Causes of death ICD-9 (1979–1998) ICD-10 (1999–present)
Certain infectious and parasitic diseases 001-139 A00-B99
Neoplasms/tumors 140-239 C00-D48
Heart diseases/diseases of the circulatory system 390-459 I00-I99
Diseases of the respiratory system 460-519 J00-J98
External causes of morbidity and mortality E800-E899 V01-Y98
**The Generalized Linear Model (GLZ) is an extension of the General Linear Model (GLM) to be used
when response variables follow distributions other than the normal distribution and when variances are
not constant.
IS SPRAWL ASSOCIATED WITH A WIDENING URBAN–SUBURBAN MORTALITY GAP? 713
or constancy of variances in traditional Poisson regression. The specification of the
GLZ model is shown below. An interaction term between the urban dummy variable
and the sprawl index is added to the model to test the hypothesis that the urbanicity-
related excess mortality is more evident in sprawling metros than in compact metros.
In other words, inclusion of the interaction term allows us to infer whether the level of
urban–suburban health disparities within a metropolitan area changes with the area’s
sprawl magnitude. Control variables of the model include age, gender, race, ethnicity,
income, and geographical division. The standard errors in the model are adjusted to
correct for correlation among counties in the same metropolitan area:
ln EðY Þf g ¼ 0 þ 1XUrban þ 2XSprawl þ 3XUrbanXSprawl þ CXControls þ "; y  Poisson
where Y is the all-cause or cause-specific mortality rates within each study county in
2000–2005 (unit: deaths per person-year), XUrban is the dummy variable as 1
represents core urban county and 0 represents suburban county, XSprawl is the
sprawl index score, XUrbanXSprawl is the interaction term of the urban dummy and
the sprawl index, XControls is a set of control variables including age, gender, race,
ethnicity, income, and geographical division, β0, β1, β2, β3, and βC are regression
coefficients, and ε is the error term.
Overall, this analysis has a national scope that improves generalizability and
uses a parallel-group design that prevents the metropolitan-level environmental
context from confounding the impact of urban residence on health. In addition,
integrating spatial factors such as the extent of sprawl into cross-sectional mortality
models helps to understand the impact of sprawl on urban–suburban health
disparities. It is expected that urban–suburban mortality gaps are more evident in
sprawling metros than in compact ones.
Findings
Table 2 presents descriptive statistics on the variables used in the national study.
Core urban counties and suburban counties differ with regard to crude mortality
rates, population composition, and socioeconomic level. In core urban counties, the
percentage of individuals aged 18–29 years tends to be higher. Population in
suburban counties (median age=36 years) are generally older than those in core
urban counties (median age=34 years). The population size and diversity of
suburban counties are much lower than urban counties. Suburban counties on
average have higher income levels than their urban counterparts.
In addition, Table 2 shows that all-cause mortality rates are higher in core urban
counties, but when looking at cause-specific mortality rates, excess mortality among
urban residents does not exist in any of the five cause-specific categories. While
death rates associated with infectious and cardiovascular diseases are higher in core
urban counties, death rates associated with tumor, respiratory, and external causes
are lower in urban counties.
The discrepancy in mortality rates between urban and suburban counties
presented in Table 2 does not adjust for demographic composition and socioeco-
nomic characteristics. Table 3 presents the regression results from the estimated
GLZ, which controls for sociodemographic confounding factors.
The results in Table 3 show that, after adjusting variations in age, race,
ethnicity, income, and regional location, the urban dummy variable is significant and


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































five cause categories, infectious diseases are associated with the highest excess
mortality among urban residents (indicated by a coefficient of 0.2462), followed by
respiratory diseases (0.1539), tumors (0.1181), cardiovascular diseases (0.1104),
and external causes (0.0473). The coefficient of 0.2462 on the urban dummy
variable in the mortality model of infectious diseases translates to an incident rate
ratio of 1.279 (1.279=exp(0.2462)). This indicates that, while holding other
variables constant and the sprawl index at 0 (note that a 0 value on the sprawl
index indicates the highest level of sprawl), residents in core urban counties on
average have an infection-related mortality risk 27.9% (pG0.01) higher than those
in suburban counties. In the all-cause mortality model, the urban dummy variable
has a coefficient of 0.0936, indicating that, while holding other variables constant
and the sprawl index at 0, the overall mortality risk in core urban counties on
average is about 10% (pG0.05) higher than that of suburban counties (10%=100%
× exp(0.0936)−100%). Likewise, in the most sprawling metropolitan areas where
the sprawl index is close to 0, urban residents on average have 11.7% higher risk of
tumor-caused death, 12.5% higher risk of cardiovascular mortality, and 16.6%
higher risk of respiratory mortality than suburban residents.
More interestingly, coefficients on the sprawl index show that, while infection-
realted and tumor-related mortality is positively associated with (pG0.01) the sprawl
index, respiratory diseases-related mortality is negatively associated with (pG0.05)
the sprawl index. As lower sprawl index values represent more sprawling metros,
the results indicate that when holding other variables constant and holding the
urban dummy at 0 (note that the unit of analysis is the county and a 0 value on the
urban dummy variable indicates the county to be a suburban county), suburban
counties in compact metros have higher infection-related and tumor-related
mortality but lower respiratory-related mortality than suburban counties in
sprawling metros. The sprawl index in models for cardiovascular diseases and
external causes is not significant. This is consistent with our earlier expectation that
sprawl impacts health in a cause-specific way.
Negative coefficients on the interaction term provide evidence in support of our
earlier hypothesis: urban–suburban health disparities are more evident in sprawling
metros than metros implementing smart growth policies. Coefficients on control
variables show consistency with previous studies on mortality. Poorer areas with
more elderly and African Americans generally have higher mortality rates. In terms
of regional location, the New England division has the highest mortality rates caused
by infectious diseases, tumors, and respiratory diseases while the West Mountain
division has the lowest. For external causes, the New England division has the
lowest mortality rate while the West Mountain division has the highest. For all-cause
mortality, New England has the highest and West Mountain has the lowest.
To gain a better view of how urban residence, sprawling land use patterns, and their
interactionmay affect mortality rates, we estimate all-cause and cause-specific mortality
rates and the uncertainty surrounding them for urban versus suburban counties across
the range of the sprawl index, while holding other variables at their median values.
Statistical software packages including Clarify 2.0 and Stata 8.0 are used to estimate the
expected values and their uncertainty.27 For the case of a typical core urban county
and the other case of a typical suburban county, expected value algorithm is repeated
to approximate 90% confidence interval around mortality rates. We then plot the
estimated expected values and the range of uncertainty in Figure 3, which illustrates
the regression findings in Table 3 quite sharply. That is, the urban–suburban mortality
gap, illustrated by the distance between blue dashed lines and black solid lines,
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generally shrinks as the sprawl index increases (i.e., the built environment becomes
less sprawling). Figure 3 shows that, in the most sprawling metros (sprawl index=0),
mortality rates in core urban counties are significantly higher than those of suburban
counties. In the least sprawling metros (sprawl index=180), no significant differences
in mortality rates can be detected between core urban and suburban counties.
More specifically, in the U.S. most sprawling metros (e.g., Riverside, CAwhere the
sprawl index score is 14.22), health disparities burdening urban residents ( or the urban
health penalty) translate to approximately 75 deaths per million persons caused by
infectious diseases, approximately 200 deaths per million population caused by tumors/
neoplasms, approximately 500 deaths per million caused by cardiovascular diseases,
and approximately 100 deaths per million population caused by respiratory diseases. In
terms of overall mortality, in the most sprawling metros, the model predicts an excess
mortality of 1,300 deaths per million in core urban counties compared to suburban
counties, after adjustment for socioeconomic characteristics and demographic compo-
sition. For less sprawlingmetros, Figure 3 shows converging confidence intervals between
urban and suburban counties, indicating little urban–suburban mortality differentials in
FIGURE 3. Mortality rates by the sprawl index and place of residence.
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metropolitan areas with compact development patterns. Among the five cause
categories, only the model for external causes predicts neither urban–suburban mortality
differences nor interaction between sprawl and urban–suburban health disparities.
Evidence from all other models supports the association between sprawl and widening
urban–suburban mortality gaps and that such mortality gaps mainly present an urban
health penalty. This further indicates that health threats associated with sprawl tend to
impact urban residents disproportionately compared to suburban residents.
PORTLAND LONGITUDINAL STUDY: DATA, METHOD, AND FINDINGS
We choose Portland as the study area for our longitudinal study mainly because of
Portland’s recent success in reversing the trend of urban sprawl.28 Portland, a living
laboratory for efficient urban planning and living, is perhaps best known for its
urban growth boundary (UGB) and its light rail system. The UGB was established in
1979 and has expanded little since then. Under the requirements of Oregon’s land
use statutes, all land outside the UGB—with exceptions—is designated for resource
use and prohibited from urban development. All land both inside and outside the
UGB must be planned by the appropriate city or county and implemented with
corresponding zoning. Proponents argue that Portland’s UGB has successfully served
to contain urban sprawl.29 In addition, Portland has adopted a set of plans to
encourage a compact urban growth pattern. In 1995, the Portland Metro Council
adopted the 2040 growth concept, which calls for putting newcomers into dense,
mixed-use neighborhoods; developing vacant land inside the growth boundary into
relatively dense residential areas; encouraging developers to take advantage of higher-
density zoning, to redevelop existing neighborhoods, and to “infill” vacant lots; and
increasing the share of multifamily housing. The adopted growth concept was fleshed
out into a comprehensive “regional framework plan” by the end of 1997. The regional
framework plan allocates Portland neighborhoods to such categories as “regional
centers,” “town centers,” “corridors,” and “inner” and “outer neighborhoods.”30
Furthermore, Portland’s light rail transit system was established on the east side of the
metropolitan area in 1986 and expanded on the west side in 1998. The light rail
transit system runs along the corridors and connects the centers. Additionally, transit
area overlay zones with minimum density requirements and several public/private
partnerships are established to encourage high-density housing and employment
growth around station areas. Proponents claim that the system has been an effective
vehicle for creating a less auto-dependent urban development pattern.31
The fact that Portland’s major growth management/smart growth efforts started
in the late 1980s and became more evident in the 1990s offers an opportunity to
perform hypothesis-driven research with a before-and-after design. Song and Knaap’s
study found out that several smart urban development elements including more
connective neighborhoods and more accessible public transit happened since the early
1990s.28 However, time lags must be considered when looking at the impact of the
built environment on health outcomes. Evident changes in health outcomes are likely
to begin in mid-1990s. To find the most appropriate intervention year, we tried 1993,
1994, and1995 when conducting before-and-after comparisons. The year of 1994
appears to have the most evident changes in mortality rates and thereby we use 1994
as the division line defining the before and after periods. If the smart growth
movement in the Portland metro area has played a role in mitigating urban–suburban
health disparities, smaller mortality gaps between urban and suburban residents are
expected in the period after smart urban development than in the period before.
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Due to issues in data availability, the study area comprises three out of the four
counties in the Portland metropolitan area, including Washington, Multnomah, and
Clackamas Counties in Oregon. Figure 4 shows the UGB and the 71 zip code areas
in the three counties.
Data and Variables
The mortality data used in this study come from death certificates collected by the
Oregon Center of Health Statistics in years from 1989 to 2000. The 1989–2000
death certificates provide individual information on causes of death, year of death,
and residency identified by zip code. We aggregated the individual mortality data by
year of death and zip code, resulting in a total of 142 data points (i.e., 71 mortality
rates at the zip code level in the before period and another 71 in the after period). As
the ICD codes for underlying causes of death changed in 1999, bridging codes in
Table 1 are used to convert ICD-9 to ICD-10.
Population density at the zip code area level is used to quantify urbanicity—the
degree to which a geographical unit is urban. All-cause and cause-specific mortality
rates are regressed on the urbanicity indicator, a dummy code of time intervals, and
an interaction term between them to quantify how the effect of urbanity on
mortality rates changed over time, while controlling for sociodemographic
composition of the zip code area. Census 1990 and 2000 data are used to generate
values on population density and control variables, respectively, in the before
(1989–1994) and after (1995–2000) periods.
Regression Model
GLZ are used again tomodel zip code-level mortality rates in the before and after periods.
The model specification is shown below. The standard errors in the model are adjusted to
correct for the correlation between before and after periods in the same zip code area:
ln EðY Þf g ¼ 0 þ 1XUrban þ 2XAfter þ 3XUrbanXAfter þ CXControls þ "; y  Poisson
where Y is the all-cause or cause-specific mortality rates within the specific time
period in the zip code area (unit: deaths per person-year), XUrban is the urbanicity
indicator represented by the population density at the zip code area level (unit: 100























































































































































































































































































































































































































































































































































































































































IS SPRAWL ASSOCIATED WITH A WIDENING URBAN–SUBURBAN MORTALITY GAP? 721
persons per square mile), XAfter is the dummy code of time intervals (1 represents the
after period from 1995 to 2000 and 0 represents the before period from 1989 to
1994), XUrbanXAfter is the interaction term of the urbanicity indicator and the time
dummy, XControls is the set of control variables including age, sex, race, ethnicity,
marital status, and income, β0, β1, β2, β3, and βC are regression coefficients, and ε is
the error term.
Findings
Table 4 provides descriptive statistics of various variables in the before and after
periods in Portland metro’s 71 zip code areas. On average, when comparing the
after period (1995–2000) with the before period (1989–1994), the Portland metro
experienced a drop in all-cause mortality from 8,814 to 7,725 deaths per million
persons per year. Mortality rates of the five cause-specific categories all decreased
over time except externally caused mortality. However, without adjustment for
demographic composition and socioeconomic characteristics and without relating
mortality rates to urbanicity, decreases in crude mortality rates provide insufficient
evidence that mortality risks among Portland residents have declined in the past
decade.
Descriptive statistics in Table 4 also show time variations in Portland’s
demographic composition. During the past decade, the Portland metro became
more populated and attracted more Hispanic/Latino immigrants. The area saw
moderate changes in age distribution. The 50–64 age group increased from 12% in
1990 to 16% in 2000 while the 65+ age group decreased from 12% to 10%.
Percentage of married households dropped from 56% in 1999 to 51% in 2000. The
gender distribution did not change much in the Portland metropolitan area during
the past decade. Large standard deviations and wide ranges shown in Table 4
suggest that substantial variation in mortality rates and sociodemographic attributes
exists at the zip code area level.
Table 5 presents regression results from the Portland longitudinal study. Results
suggest that, after adjustments for sociodemographic characteristics at the zip code
area level, urbanicity-related excess mortality is only observed in the infection
category. Only infection-caused mortality is positively related to the urbanicity
factor measured by population density, shown by a positive regression coefficient of
0.0052. Coefficients on the urbanicity factor in other models are all negative and
significant, indicating that all-cause mortality rates and most cause-specific rates
such as tumor, cardiovascular and respiratory diseases, and external causes decrease
as the urbanicity of a zip code area increases. In other words, in 1989–1994,
Portland not only experienced an urban health penalty (indicated by results from the
model for infectious diseases) but to some degree also experienced an urban health
advantage (indicated by other models).
Coefficients on the time dummy variable are negative and significant in all the
models, indicating that, while holding other variables constant, all-cause and cause-
specific mortality rates decreased over time. This finding supports our early
expectation that Portland’s extensive efforts on curbing sprawl are associated with
net decreases in the metro’s mortality rates. Coefficients on the interaction term
between time and urbanicity show different directions and magnitudes across the six
models. However, the interaction term in each of the six models always has a
different sign from the urbanicity factor. This pattern suggests narrowed urban–
suburban mortality gaps (either urban penalty or advantage) in the after period. For
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factor suggests an urban health penalty in the before period and the negative
coefficient on the interaction term suggests a decline of the urban health penalty over
time. This further indicates that Portland’s efforts on curbing sprawl are associated
with mitigated urban–suburban health disparities.
Most coefficients on control variables show consistency with previous mortality
studies. Poorer areas with more elderly and African Americans generally have higher
mortality rates. Areas with higher ratio of married households are generally
associated with lower mortality rates. Furthermore, larger male population is
associated with higher externally caused mortality but lower infection-caused and
cardiovascular-related mortality.
To better understand how the time and urbanicity factors affect health outcomes,
all-cause and cause-specific mortality rates and the uncertainty surrounding them are
estimated for the before versus after periods across the range of urbanicity, while
holding other variables at their medians. For a typical zip code area in the before
period (1989–1994) and a typical zip code area in the after period (1994–2000),
FIGURE 5. Mortality rates by time and urbanicity.
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expected value algorithm is repeated to approximate how the 90% confidence interval
of mortality rates changes by urbanicity. Statistical software packages including
Clarify 2.0 and Stata 8.0 are used again to estimate the expected values and their
uncertainty. The estimated results are visually presented in Figure 5.27
Figure 5 reinforces the regression findings presented in Table 5. Lines presenting
the before period (blue dashed lines in Fig. 5) has steeper increasing or declining
trends than the lines presenting the after period (black solid lines). This indicates
that, in years 1989–1994, urbanicity-related mortality gaps existed in the Portland
metro (i.e., area-based mortality rates change as urbanicity varies). However, urban–
suburban mortality gaps existed in years 1989–1994—either urban penalty or
advantage—all became less evident in the after period (1994–2000). Furthermore,
Fig. 5 shows upward lines when relating infection-caused mortality to urbanicity but
downward trends when relating other mortality rates to urbanicity. This suggests
that, while the model for infectious diseases predicts excess mortality among urban
residents in the Portland metropolitan area, all other models predict elevated
mortality among suburban residents in the metro.
CONCLUSIONS AND DISCUSSION
In this paper, we examine whether sprawl is associated with a wider mortality gap
between urban and suburban residents. Our national cross-sectional study and
Portland longitudinal study provide the only evidence to date that (1) across
metropolitan areas, the size of urban–suburban mortality gaps varies by the extent
of sprawl: in sprawling metropolitan areas, urban residents have significant excess
mortality risks than suburban residents, while in compact metropolitan areas,
urbanicity-related excess mortality becomes insignificant; (2) the Portland metro-
politan area not only experienced net decreases in mortality rates but also a
narrowing urban–suburban mortality gap since its adoption of smart growth regime
in the past decade; and (3) the existence of excess mortality among urban residents
in US sprawling metropolitan areas, as well as the net mortality decreases and
narrowing urban–suburban mortality gaps in the Portland metropolitan area, is not
attributable to sociodemographic variations. The national and Portland studies,
although very different in scope and approach, point to similar directions. Both
suggest a positive association between sprawl and urban–suburban health dispar-
ities. This further indicates that growth management strategies and policies such as
UGB and impact fees may reduce the mortality gap between urban and suburban
residents through curbing and preventing sprawl.32
When looking at cause-specific mortality, infectious diseases and external causes
show unique patterns from all other causes. Excess mortality among urban residents
is most evident when examining infection mortality rates, shown by a much larger
coefficient on the urban dummy variable in Table 3 and the positive relationship
between infectious disease mortality and urbanicity in the Portland study. The high
relevance of infection deaths to urbanicity suggests that crowding and density pose
health risks to residents, perhaps potentiated by rapid transmission from one person
or specie to another in populated urban environments. External causes also show
unique mortality patterns. In the national study, the external causes model is the
only model that shows no significant association among mortality rates, urbanicity,
and sprawl. This finding contradicts the general perception that living in cities is
equated with higher risks of accidental deaths due to exposure to more traffic
accidents and violent crimes. However, the finding concurs with previous empirical
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findings.5,33 A possible explanation is that the model estimates mortality rates rather
than the absolute number of deaths and people tend to mistakenly perceive higher
risks in cities because of the high absolute number of accidental deaths.
Most importantly, while much research on sprawl has identified negative health
consequences of sprawl,20–22 our research has shown that it is also important to
investigate the spatial distribution of health outcomes within the metropolitan area
and especially the health disparity issues between central cities and suburbs. By
looking at how sprawl and urbanicity may interactively affect mortality, we find that
sprawl is associated with not only net mortality increases at the metropolitan level
but also wider intrametropolitan mortality gaps between urban and suburban
residents. Mortality risks imposed by sprawl affect urban residents disproportion-
ately compared to suburban residents. In other words, this paper provides
convincing evidence on the notion “sprawl is bad for health” without contradicting
the fact “suburban residents are generally healthier.”
Although the research provides a framework for examining the sprawl–health
inequity association, the framework is largely preliminary and exploratory and
raises important issues for future research. For example, when investigating health
disparities burdening urban residents, both measuring health and defining urbanicity
determine the results.34 While level of urbanization can be conveniently used to
categorize urban versus suburban areas, this scheme may mask important differ-
ences within urban or suburban areas.35 An attempt should be made to develop
alternative measurements of urbanicity. Furthermore, the national mortality analysis
is conducted at the county level, which admittedly limits the interpretation of the
analysis results. Within the same county, the built environment may vary
considerably. Future research may be conducted at more disaggregate levels to
develop a finer-grained understanding of how neighborhood-level built environment
features may contribute to urban–suburban health disparities. In addition,
information on housing location choice among urban/suburban residents may be
collected to address self-selection bias—the issue that healthier people select
themselves to “healthier” places. Finally, the transferability of findings from our
Portland longitudinal study is somewhat limited. Researchers can apply the
longitudinal approach to a much larger and more diverse sample of metropolitan
areas. We hope that this study will stimulate research on the relationship between
sprawl and health disparities.
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